HCA Healthcare, Inc.
Every calculator, already run for HCA
Open the full toolkit →You have the numbers on HCA. Get the argument.
A written report on which of these readings actually decide the outcome for HCA Healthcare, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
26 analysts covering HCAAnalyst Price Target Disagreement for HCA Healthcare, Inc.
Wall Street's bull case implies +34% from the current price; the bear case implies -12%. A 46% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for HCA
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency se…
HCA — frequently asked
Is HCA a buy right now?
Wall Street's consensus rating on HCA Healthcare, Inc. is Buy across 26 analysts, with a mean price target of $454.23 (+5% vs. the current $432.60). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is HCA overvalued?
HCA trades at 14.6x trailing earnings, against a DCF fair value of $441 per share. The current price implies 6% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is HCA's next earnings date?
HCA Healthcare, Inc. is next scheduled to report earnings around Oct 23, 2026. A full HCA research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for HCA Healthcare, Inc.?
Analysts covering HCA Healthcare, Inc. (HCA) range from a bear-case target of $380.00 to a bull-case high of $579.00, with a mean consensus target of $454.23 across 22 analysts. The spread of $199.00 (46% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare HCA Healthcare, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For HCA Healthcare, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full HCA research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on HCA Healthcare, Inc., in minutes. 3 free reports included with every account — no credit card required.